SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027662
Filing Date
2021-05-14
Accepted
2021-05-13 17:38:45
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-10q_20210331.htm 10-Q 1711107
2 EX-10.1 etnb-ex101_9.htm EX-10.1 54749
3 EX-10.2 etnb-ex102_86.htm EX-10.2 57557
4 EX-31.1 etnb-ex311_8.htm EX-31.1 20138
5 EX-31.2 etnb-ex312_7.htm EX-31.2 20166
6 EX-32 etnb-ex32_6.htm EX-32 15600
  Complete submission text file 0001564590-21-027662.txt   5439739

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT etnb-20210331.xml EX-101.INS 1105837
8 XBRL TAXONOMY EXTENSION SCHEMA etnb-20210331.xsd EX-101.SCH 32004
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etnb-20210331_cal.xml EX-101.CAL 33155
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20210331_def.xml EX-101.DEF 99997
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20210331_lab.xml EX-101.LAB 301766
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20210331_pre.xml EX-101.PRE 209481
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 21921031
SIC: 2834 Pharmaceutical Preparations